Issue 1, 2023
From the journal:

RSC Advances

Correction: Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)

Ritika Sharma, ORCID logo a   Anchala Kumari, ORCID logo b   Bishwajit Kundu ORCID logo c  and  Abhinav Grover ORCID logo *a  

* Corresponding authors

a School of Biotechnology, Jawaharlal Nehru University, New Delhi-110067, India
E-mail: sharma.ritika198@gmail.com, abhinavgr@gmail.com
Tel: +91-8130738032

b Indian Council of Medical Research, International Health Division, New Delhi-110029, India
E-mail: anchala.choudhary27@gmail.com

c Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, India – 110016
E-mail: bkundu@bioschool.iitd.ac.in

Abstract

Correction for ‘Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)’ by Ritika Sharma et al., RSC Adv., 2022, 12, 29469–29481, https://doi.org/10.1039/D2RA05061G.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2RA90131E
Article type
Correction
Submitted
16 Dec 2022
Accepted
16 Dec 2022
First published
23 Dec 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2023,13, 720-720

Permissions

Request permissions

Correction: Amyloid fibrillation of the glaucoma associated myocilin protein is inhibited by epicatechin gallate (ECG)

R. Sharma, A. Kumari, B. Kundu and A. Grover, RSC Adv., 2023, 13, 720 DOI: 10.1039/D2RA90131E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements